Multi-Jurisdictional CAC Meeting Announcement - MolDX: Biomarker Risk Stratification Testing in DCIS - April 22, 2024, 2 p.m. to 4 p.m. ET

This article has been published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Palmetto GBA, CGS Administrators, Noridian Healthcare Solutions and WPS Government Health Administrators will host a Multi-Jurisdictional Contractor Advisory Committee (CAC) Meeting via Microsoft Teams Webinar on April 22, 2024, from 2 - 4 p.m. ET. Discussions will focus on MolDX: Biomarker Risk Stratification Testing in DCIS

The Centers for Medicare & Medicaid Services (CMS) assigned Medicare Administrative Contractors (MACs) the task of developing Local Coverage Determinations (LCDs). The CAC meeting provides a formal mechanism for healthcare professionals to be informed of the evidence used in developing an LCD and promote communications between the MACs and the healthcare community. The CAC panel will discuss the clinical literature related to MolDX: Biomarker Risk Stratification Testing in DCIS and rate their confidence in a series of Key Questions. Discussions will occur between CAC panelists and Contractor Medical Directors. The public may attend; however, questions from the public will not be entertained.

Interested stakeholders are invited to listen via Microsoft Teams Webinar; however, advance registration is required. Register here MoIDX CAC Meeting You will receive your confirmation email once you complete registration.

Note: Registration deadline is April 21, 2024, 11:59 p.m. ET.

Lines will remain muted throughout the conference except for the invited CAC panelists and the MAC hosts.

View meeting details and register now from the CAC Meeting webpage.

Last Updated Apr 08 , 2024